THE APEX TIMES
Raytheon Technologies (RTX) reported third quarter 2026 revenue of $24.97 billion and net income of $2.58 billion, with adjusted earnings per share above prior consensus expectations. The company’s board also declared a $0.73 per share dividend.
RTX said it delivered a stronger-than-anticipated earnings showing in its third quarter of 2026, a result highlighted in a market report that also noted a shareholder payout. The aerospace and defense contractor reported revenue of $24.97 billion and net income of $2.58 billion for the quarter.
The key investor focus, according to the same report, was adjusted earnings per share. RTX’s adjusted EPS came in above prior consensus expectations, implying the company’s earnings performance beat what analysts had expected before the release. Adjusted EPS is a profit measure that typically excludes certain items management believes are not reflective of core operations, and it is often used by investors to compare results across periods.
Alongside the profit and revenue figures, RTX’s board declared a quarterly dividend of $0.73 per share. A declared dividend indicates the company’s intent to return cash to shareholders even while it continues to invest in defense programs and industrial capacity across its portfolio.
For investors tracking the defense sector, RTX’s results land amid heightened attention to government spending and defense procurement cycles, where order timing, program milestones, and contract mix can materially affect quarter-by-quarter performance. Even when revenue rises, margins can swing based on cost trends, delivery schedules, and the pace of work on major programs.
RTX’s third quarter numbers also reinforce the importance of adjusted profitability measures in the defense market. While net income of $2.58 billion provides a broad snapshot of profitability, the report’s emphasis on adjusted EPS suggests investors were looking for evidence that operating conditions remained supportive, not just that accounting items improved the headline result.
Company guidance and forward-looking detail were not included in the brief market item. The report also did not specify any changes to its outlook, contract backlog levels, or program-level performance, so it remains unclear what portion of the beat, if any, came from better-than-expected execution versus accounting and timing factors.
What to watch next for RTX is whether the adjusted EPS strength proves sustainable in subsequent quarters, especially as procurement and production schedules can shift. Investors will likely also focus on whether future dividend declarations remain consistent, and whether RTX provides more detail on earnings drivers when it files its full results materials and management commentary.
Greg Penner, Walmart’s chairman, and his wife Carrie Penner have reportedly added Spanish soccer club Valencia CF to their portfolio, alongside stakes in major U.S. sports teams.
In comments highlighted from its latest earnings call, Palantir said accelerating “sovereign AI” demand and continued deployment activity are driving an improved view for 2026, with growth tied to both U.S. commercial customers and defense programs.
In a new investor letter released as part of its “Thematic Growth Strategy,” Mott Capital pointed to Microsoft’s fiscal fourth-quarter results and reported that its strategy was up 9.01% year-to-date.
Despite a high-profile warning that China’s open-source AI model ecosystem could be used to steer demand toward domestic chips, investors bid up major semiconductor names on Tuesday.
With biotech investors calibrating expectations across earnings and clinical milestones, Moderna gained momentum before its results, Pfizer’s stock eased even as the company improved its guidance, and Merck declined amid a new late-stage trial update.
In a market session marked by weakness early in the day, Palantir shares gained ground after trading off their lows. Chip stocks outperformed, while a broader set of investors focused on insurance names framed as potential “entry points.”
After a third-quarter beat and an upgraded outlook, Pfizer’s strategy pitch centered on major dealmaking. A portfolio manager cautioned that the real proof will arrive later.
The company says it has put more than $10 billion into Kansas since 2010 and credits education and upskilling efforts with growing local employment opportunities.
Palantir (PLTR) reported results that beat Wall Street expectations, but the stock fell in premarket trading after investors appeared to question what the quarter’s contract trends imply for the company’s near-term outlook.
The Pershing Square founder questioned the market’s current price swings, attributing them to speculative trading and leverage, while naming several large consumer and financial-services companies he still views as durable holdings.
